← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Intronn, Inc.
Rockville, MD
$7,256,111
Total funding
7
Grants
Funding over time
peak $1.6M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$7,256,111 · 7
By mechanism
R44$5,475,937 · 2
R43$1,356,411 · 4
R21$423,763 · 1
Investigators at Intronn, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Repair of Factor VIII by targeted RNA trans-splicing$1,489,114
R44 · FY2006 · HL
TRANS-SPLICING TO REPAIR CYSTIC FIBROSIS MRNA$1,357,285
R44 · FY2001 · DK
Repair of Factor VIII by targeted RNA trans-splicing$1,191,834
R44 · FY2005 · HL
TRANS-SPLICING TO REPAIR CYSTIC FIBROSIS MRNA$875,498
R44 · FY2000 · DK
Repair of Factor VIII by targeted RNA trans splicing$596,898
R43 · FY2003 · HL
TRANS-SPLICING TO REPAIR CYSTIC FIBROSIS MRNA$562,206
R44 · FY2001 · DK
Development of SMaRT gene therapy for Cystic Fibrosis$223,973
R43 · FY2003 · DK
Pre-mRNA Trans-Splicing for Molecular Imaging of Cancer$218,638
R43 · FY2003 · CA
Pre-mRNA Trans-Splicing for Molecular Imaging of Cancer$215,428
R43 · FY2002 · CA
Use of RNA trans-splicing to identify splice sites$215,013
R21 · FY2005 · HG
Use of RNA trans-splicing to identify splice sites$208,750
R21 · FY2004 · HG
Generation of interfering RNA molecules by trans-splicing$101,474
R43 · FY2006 · GM